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Abstract
Background: Food allergy is increasingly common worldwide. Tools for allergy diagnosis measuring IgE improved much
since allergenic molecules and microarrays started to be used. IgE response toward allergens belonging to the same group
of molecules has not been comprehensively explored using such approach yet.
Objective: Using the model of lipid transfer proteins (LTPs) from plants as allergens, including two new structures, we
sought to define how heterogeneous is the behavior of homologous proteins.
Methods: Two new allergenic LTPs, Act d 10 and Act c 10, have been identified in green (Actinidia deliciosa) and gold
(Actinidia chinensis) kiwifruit (KF), respectively, using clinically characterized allergic patients, and their biochemical features
comparatively evaluated by means of amino acid sequence alignments. Along with other five LTPs from peach, mulberry,
hazelnut, peanut, mugwort, KF LTPs, preliminary tested positive for IgE, have been immobilized on a microarray, used for
IgE testing 1,003 allergic subjects. Comparative analysis has been carried out.
Results: Alignment of Act d 10 primary structure with the other allergenic LTPs shows amino acid identities to be in a
narrow range between 40 and 55%, with a number of substitutions making the sequences quite different from each other.
Although peach LTP dominates the IgE immune response in terms of prevalence, epitope recognition driven by sequence
heterogeneity has been recorded to be distributed in a wide range of behaviors. KF LTPs IgE positive results were obtained
in a patient subset IgE positive for the peach LTP. Anyhow, the negative results on homologous molecules allowed us to
reintroduce KF in patients’ diet.
Conclusion: The biochemical nature of allergenic molecule belonging to a group of homologous ones should not be taken
as proof of immunological recognition as well. The availability of panels of homologous molecules to be tested using
microarrays is valuable to address the therapeutic intervention.
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Introduction
Allergic disease prevalence is on the increase worldwide, and
recent reports show that food allergy is going to be a greater
problem than before [1]. Thus there is the need for a robust
understanding of all aspects characterizing IgE response to
allergens, being the IgE production the first step for allergy-
mediated food hypersensitivity [2]. A great help in the process of a
better knowledge in the field is coming from the increasing
number of allergenic molecules identified so far (http://www.
allergome.org/script/statistic.php) and made available for studies
in combination with micro-technology [3]. Such combination
allows exploring in deep details relationships among structurally
distant as well as closely related homologous molecules [4].
The grouping of allergens in families because of their
biochemical structure is leading to assign a similar IgE immune-
recognition to similar structures, furthermore supported by in silico
studies [5]. Allergenic molecules are in fact currently considered to
be a unique entity because of their biochemical definition [6,7].
That is the case of many allergen families, which got the definition
of panallergens because of their distribution in certain distant
subsets of living organisms rather than for their real and obvious
IgE pan-recognition of protein structures [8]. Recent reports based
on broad IgE testing using the powerful combination mentioned
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homologous structure could be influenced by other factors not
easily interpreted just using the molecule structures [4].
Nowadays there is a claim for a more personalized medicine.
Such claim seems to fit perfectly in the allergy field where the
clinical phenotype is tightly linked to the IgE immune recognition
and each patient seems to display a different clinical picture when
compared to another. Such personalized approach, formerly
almost impossible because of the number of tests to be performed
in each patient, is now becoming increasingly feasible because of
the biotechnology/microtechnology combination supported by
information technology tools recently made available for the
routine work [3,9].
Plant LTPs are widely distributed, structurally related, small
proteins involved in defense mechanisms. Although their lipid-
binding ability has been well reported, the biological function of
LTPs is still largely unknown. The plant LTP family includes two
subfamilies according to their molecular masses: the 9-kDa LTP1
and the 7-kDa LTP2. Although LTP1 and LTP2 share a common
compact fold consisting of four a-helices stabilized by four disulfide
bridges, the pairing partners of cysteines are not completely
conserved between the two subfamilies, that also display a low
overall sequence similarity (about 30% identity) [10].
Up to now 63 LTPs have been characterized as allergens, being
46 of them expressed in edible parts of plants, almost all of them
belonging to the LTP1 protein subfamily, and just two, having
very preliminary reported data, to the LTP2 subfamily (www.
allergome.org, accessed September 12, 2011).
Several reviews on the topic of LTP as allergens reported
preliminary evidence of a heterogeneous behavior of this group of
molecules [11–13], but few of them suggested strategies how to
overcome the peculiarity of such behavior within a routine workup
[13]. Unless we performed a broad study on 23,077 subjects using
the microarray approach, we could not have evidence of such
heterogeneity as we had just the LTP from peach available on the
microarray used at the time the study had been performed [4].
Taking advantage of the implementation of a full molecule-,
microtechnology-, and information technology-based infrastruc-
ture at the Center in Rome, Italy, and of the expansion of the
number of available LTPs to a panel of seven allergens, including
two new proteins identified in the kiwifruits (KF), we sought to
compare the LTP biochemical, immunochemical, and clinical
features in order to define the extent of their heterogeneity. The
study, leading first to the full characterization of KF LTPs,
brought us to abandon the former interpretation of ‘‘one molecule
fits all’’ and to search for as much differences as possible among
allergenic proteins facing each allergic patient, in order to increase
the quality of personal decision making he or she deserves.
Materials and Methods
Allergic subjects
The study received the approval of the Institutional ethical
committee of the Istituto Dermopatico dell’Immacolata, Rome,
Italy (66/CE/2006). Patients or caregivers signed an informed
consent when undergoing tests not in the routine workup. Patients’
demographical and clinical data, namely respiratory and inges-
tion-related symptoms on KF exposure, as well as all the in vivo
and in vitro diagnostic data, were recorded for all patients by an
allergy specialist, or transferred real time from the laboratory, into
the InterAll software, a customized allergy electronic record for
diagnostic and clinical data storing (version 3.0, Allergy Data
Laboratories s.c., Latina, Italy). KF specific clinical information
were collected using the standard questionnaire reported in a
previous study [14]. Patients who underwent clinical tests, like the
skin test (ST) or the double blind placebo controlled food challenge
(DBPCFC), were selected for any given study procedure following
criteria reported in the Result section.
A subset of 259 consecutive subjects, tested nPru p 3 positive on
the Immunosolid phase Allergen Chip (ISAC) 103 (Phadia
Multiplexing Diagnostics, PMD, Vienna, Austria), was tested on
the ISAC Exp96 (PMD, see below for details). To verify the
presence of LTP IgE positive subjects beside the nPru p 3 in the
subset reported above, a control population of 744 consecutive
allergic subjects tested positive to any allergen on ISAC 103 has
been created. Overall 1,003 subjects underwent IgE testing with
the ISAC Exp96 microarray.
Clinical testing
ST were performed and recorded as wheal areas using a
standard methodology as already reported [14]. The following
preparations were used: a commercial KF extract (Stallergenes,
Antony, France), fresh KFs tested by means of the prick-prick
technique, the green KF pulp and seed preparations, natural (n)
purified Act d 10, nAct c 10, and nPru p 3. Details on the last five
preparations are given below.
KF and peach DBPCFC have been performed as reported in
literature in enrolled subjects when they did not report a recent
anaphylaxis episode [14,15]. In case of patients reporting recent
anaphylaxis after KF or peach ingestion, it was taken as a proof of
clinical allergy in accordance with the most recent European
guidelines for the diagnosis of clinically relevant food allergy [16].
Laboratory testing
Singleplexing IgE detection. Total and specific IgE using a
singleplex system were determined in patients’ sera from venous
blood samples obtained at the time of enrolment by the
ImmunoCAP system (Phadia AB, Uppsala, Sweden). To verify
the IgE binding capability of the new KF LTPs, biotinylated nAct
d 10 and nAct c 10 (see below) have been coupled on a
streptavidin-CAP following the standard methodology as
suggested by the manufacturer (Phadia) and reported in
literature [17].
Multiplexing IgE detection. Specific IgE for allergenic
molecules were detected by ISAC 103 microarray test (PMD);
ISAC tests were performed as previously reported [4]. A
customized version of the ISAC microarray (ISAC Exp96) has
been developed to carry out the characterization of the IgE
reactivity toward the new KF LTPs and some others not available
on the commercial ISAC 103. For the purpose of the present
study, data on nPru p 3, the peach LTP, recombinant H Cor a 8,
the hazelnut LTP, and nArt v 3, the mugwort pollen LTP, were
obtained using the commercial ISAC 103 microarray. rAra h 9,
the peanut LTP, provided by Phadia, and nAct d 10, nAct c 10,
nMor n 3, the mulberry LTP, and the nPru p 3 in-house
preparations were immobilized on ISAC Exp96 microarray,
following the same methodology as for the routine ISAC 103
[18]. Details on each allergen biochemical, immunological, and
clinical features are available via the Allergome web site (www.
allergome.org) [9].
Single Point Highest Inhibition Achievable assay
(SPHIAa). IgE inhibition experiments have been performed
applying the SPHIAa as previously reported [14]. Briefly, 20 mlo f
individual patients’ sera have been incubated overnight with 20 ml
of a solution containing the highly purified allergen preparation of
nAct c 10, nAct d 10, nPru p 3, at 1 mg/ml concentration, or the
simulated gastric fluid (SGF) or the trypsin digested preparations at
the same concentrations. Whole KF, pulp and seed extract
Non-Homogeneous LTP Behavior in Allergic Subjects
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considering their total protein content. All the above preparations
acted as inhibitors of the IgE binding. After o.n. incubation, the IgE
binding inhibition was evaluated by running the ISAC Exp96
microarray (PMD) where the IgE reactivity was evaluated on all
immobilized nAct c 10, nAct d 10, rAra h 9, nArt v 3, rCor a 8,
nMor n 3, and nPru p 3 at the same time, or on some of them
depending on the experiments as described in details in the Results
section. A controlsample, where only the buffer solutionwas added,
was used as reference value for no IgE inhibition. A trypsin solution
has been added to controls when the SPHIAa using digested
preparations was performed. To control the specificity of the IgE
inhibition obtained on LTP molecules, several other allergens
available on the two microarrays which were recognized by the IgE
of the same patient or the pool were used. A no-inhibition value on
those allergens was required to score the experiment as valuable. All
IgEinhibition datawerestoredintheInterAlldatabase,andpercent
inhibition values were calculated real time by a specific procedure
developed within the InterAll software.
Preparation of the protein extracts from whole kiwifruit
Gold KF (Actinidia chinensis) and green KF (Actinidia deliciosa) were
purchased at a local market. KFs were peeled, homogenized in a
household blender after addition of 1 M NaCl (1:1 w/v) and stirred
at 4uC for 2 h. After centrifugation at 12,500 x g for 60 min, the
supernatant representing the total protein extract was collected,
dialyzed against water, aliquoted and stored at 220uC until used.
Preparation of protein extracts from pulp and from seeds
Seeds of gold and green KFs were manually separated from the
pulp. Pulp samples were homogenized in a blender after addition
of 1 M NaCl (1:1 w/v) and stirred at 4uC for 2 h. Seeds were
crushed by pestle in a mortar until a smooth powder was obtained.
Seed proteins were extracted in 0.5 M NaCl, at 4uC for 2 h. After
protein extraction, pulp and seed samples were centrifuged at
12500 x g for 60 min and the supernatants were collected.
Determination of the protein concentration
The protein concentration in the extracts was estimated by the
BIO-RAD Protein Assay (Bio-Rad, Milan, Italy), using calibration
curves made with bovine serum albumin.
Protein extracts fractionation by RP-HPLC
RP- HPLC of KF extracts was performed on a Vydac
(Deerfield, IL, USA) C8 column (0.21625 cm), using a Beckman
System Gold apparatus (Fullerton, CA, USA). Elution was
accomplished by a multistep linear gradient of eluant B (0.08%
TFA in acetonitrile) in eluant A (0.1% TFA) at a flow rate of 1 ml/
min. The eluate was monitored at 220 and 280 nm. The separated
fractions were manually collected and analyzed.
Purification of LTP from gold and green kiwifruits
KF LTPs, namely nAct c 10 and nAct d 10, were extracted from
seeds and purified from the seed extracts using the procedure
described by Ciardiello et al. [19]. nPru p 3 and nMor n 3 were
purified from peach peel and from the whole black mulberry fruit,
respectively, as previously reported [19]. Purity of the protein
preparations was checked by SDS-PAGE, RP- HPLC and N-
terminal amino acid sequencing.
Molecular mass of purified LTPs
The molecular mass of purified proteins was estimated by
MALDI-TOF mass spectrometry measurements carried out on a
PerSeptive Biosystems (Framingham, MA, USA) Voyager-DE
Biospectrometry Workstation. Analyses were performed on pre-
mixed solutions prepared by diluting samples (final concentration
5 pmol/ml) in 4 volumes of matrix, namely 10 mg/ml a-ciano-4-
hydroxycinnamic acid in 60% acetonitrile containing 0.3% TFA.
Treatment of purified LTPs with SGF and trypsin
In vitro simulated gastric digestion of nAct d 10 and nPru p 3
was performed as described by Bublin et al. [20]. LTPs were
subjected to pepsin digestion (Roche Diagnostics GmbH, Ger-
many) using an enzyme/substrate ratio of 1: 20 w/w. The
incubation was performed in SGF (0.15 M NaCl adjusted with
1M HCl to pH 2) at 37uC. Aliquots were taken at 0 and 120 min
and analyzed by SDS-PAGE and RP-HPLC. The digestion was
stopped by raising the pH to 7.4 by addition of 50 mM Na-
Phosphate pH 7.4 and the samples were stored at 220uC. LTP
samples were subjected to trypsin digestion (Roche Diagnostics
GmbH, Germany) using an enzyme/substrate ratio of 1: 20 w/w.
The incubation was performed in 1% ammonium bicarbonate, at
37uC. Aliquots were taken at 0 and 120 min and analyzed by
SDS-PAGE and RP-HPLC. The digestion was stopped by boiling
the sample for 2 min. The samples were then vacuum dried,
washed three times with water to remove traces of ammonium
bicarbonate, solubilized in PBS and stored at 220uC.
Act d 10 primary structure determination and analysis
Amino acid sequencing of LTP N-terminal region was
performed with an Applied Biosystems Procise 492 automatic
sequencer (Applied Biosystems, Foster City, CA). Denaturation
and alkylation of LTP sulfhydryl groups with 4-vinylpyridine was
carried out as already described [21]. Denatured LTP was divided
into two aliquots and subjected to proteolytic cleavage by either
trypsin or Asp-N following manufacturer’s instructions (Roche
Diagnostics GmbH, Mannheim, Germany). Due to the large size,
a peptide deriving from digestion with Asp-N was sub-digested
with chymotrypsin (Roche Diagnostics GmbH). Separation of the
peptides obtained by proteolytic cleavages and amino acid
sequencing were performed as already described [21]. Protein
sequence analyses were performed using available software on the
ExPASy Proteomics Server (www.expasy.org).
Biotinylation of kiwifruit LTPs
Purified nAct c 10 and nAct d 10 preparations (1 mg/ml, in 0.1
M sodium carbonate buffer pH 8.7) were incubated with 5 times
molar excess of biotin N-hydroxysuccinimide ester (Sigma-Aldrich,
Milano, Italy) dissolved in DMSO (Sigma-Aldrich). After 3.5 hours
at room temperature, the excess reagents were removed by gel-
filtration chromatography using a PD10 column (Amersham
Biosciences, Uppsala, Sweden) equilibrated in PBS. The biotiny-
lated preparations were then used for coupling with the
streptavidin-CAP as described above.
Protein solutions for skin test
Dialyzed protein extracts and purified LTP samples in
deionized water were mixed with sterile glycerin in a 1:1 ratio.
The final protein concentration was 0.5 mg/ml. The LTP
solutions were sterilized by membrane filtration through a 0.22-
mm filter (Millex, Millipore, Bedford, MA, USA), in a sterile
horizontal laminar flow hood.
Data storing, processing and Statistics
All diagnostic and experimental data were stored into the
InterAll e-record and underwent descriptive statistics including
Non-Homogeneous LTP Behavior in Allergic Subjects
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lence comparisons have been carried out using the x
2 test followed
by pair-wise comparison using the Tukey post hoc test.
Significances in inter-group value correlation comparisons were
evaluated by the Spearman test. Specific IgE and ST results were
expressed using median value, with interquartile ranges (5th
percentile-95th percentile) (IQR). Serum IgE values were analyzed
using the Kruskal-Wallis One-Way ANOVA by Ranks and the
pair-wise comparison with a Mann-Whitney test with Bonferroni
correction. Serum IgE percent value distribution obtained after
the inhibition assay were compared using the Kruskal-Wallis One-
Way ANOVA by Ranks, followed by the post hoc test Nemenyi-
Figure 1. Act d 10 complete primary structure. Arrows indicate fragments obtained by enzymatic digestion with trypsin (T), Asp-N (D) and
chymotrypsin (C). The amino acid sequence of the N-terminal region obtained by direct sequencing of the entire molecule is indicated by N-term.
Peptides are numbered according to their order in the sequence.
doi:10.1371/journal.pone.0027856.g001
Figure 2. Amino acid identity table and sequence alignments of Act d 10, Ara h 9, Art v 3, Cor a 8, Mor n 3, and Pru p 3. Panel A: Table
of amino acid identity reported as paired percent values; Panel B: LTP sequence alignments; Act d 10 and Pru p 3 sequence numbering are indicated
at the top and at the bottom of the alignments, respectively. Background colors identify identical amino acids as follows: Yellow: identical amino
acids in all six sequences; Blue: identical amino acids in Act d 10 and Pru p 3 and some other LTP sequences; Green: amino acids of Act d 10
substituted in Pru p 3, but conserved in at least one of the other sequences; Red: amino acids of Pru p 3 substituted in Act d 10, but conserved in at
least one of the other sequences; Brown: identical amino acids only in Act d 10 and Pru p 3 sequences; White: no amino acid identities with Act d 10
and Pru p 3 sequences.
doi:10.1371/journal.pone.0027856.g002
Non-Homogeneous LTP Behavior in Allergic Subjects
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2 or Fisher’s exact tests were applied
to contingency tables and used when appropriate depending on
the number of observations. All tests were used with two-sided
options and significance level was set at a p value,0.05. Statistical
analysis and graphical visualization of data have been performed
using the R software (www.r-project.org) and Graphpad Prism
(version 5.02, Graphpad Software Inc., La Jolla, CA, USA).
Results
Detection of LTP in kiwifruit pulp and seed protein
extracts
Seed and pulp extracts of green and gold KF were prepared,
fractionated by RP-HPLC and the separated protein components
were manually collected and analyzed by N-terminal amino acid
sequencing. The analysis of a peak eluted at a retention time very
similar to that observed for nPru p 3 allowed the identification of
the LTP, namely Act c 10 and Act d 10, in the seed extracts from
the gold and the green KFs, respectively, rather than from the
pulp (see below). Act c 10 was eluted as a single peak, whereas Act
d 10 was eluted in three overlapping peaks suggesting the presence
of some isoforms. Direct protein sequencing of the purified protein
allowed the identification of two different isoforms of Act d 10 (see
below). Possible additional isoforms were not identified probably
because of the low yield. Conversely, the LTP peak was absent in
Table 1. Diagnostic profiles of seven selected kiwifruit allergic patients used for the initial characterization of kiwifruit LTPs.
A.
Subjects InterAll APC Code Age Gender Symptoms6 Total IgE Skin test* CAP IgE** DBPCFC6 ISAC 103 IgE**
Commercial
extract Prick-Prick
Commercial
extract Act d 1 Pru p 3
1 ITROMIDI28837 26 M URT 1254 18.00 Neg Neg URT Neg 1.07
2 ITROMIDI21272 40 M URT 790 Neg Neg 4.10 URT Neg 1.01
3 ITROMIDI24698 37 F OAS 11 43.69 89.05 1.24 URT Neg 3.61
4 ITROMIDI24232 31 F GI - URT 65 Neg 29.39 1.02 GI - URT Neg 1.89
5 ITROMIDI28626 16 M GI 450 Neg 60.06 3.40 URT 4.34 9.35
6 ITROMIDI1558 28 M GI - URT 211 56.00 109.11 0.84 GI - URT Neg 2.70
7 ITROMIDI5272 27 F OAS 2500 17.34 23.76 7.00 URT Neg 5.46
B.
Subjects
InterAll APC
Code Age Gender Skin test* CAP IgE** ISAC Exp96 IgE**
Act d 10 Act c 10 Pru p 3 Act d 10 Act c 10 Act d 10 Act c 10
Pru p
366
1 ITROMIDI28837 26 M 15.00 100.40 78.00 0.74 0.93 0.70 0.43 2.59
2 ITROMIDI21272 40 M 27.00 36.00 12.00 25.90 65.90 9.91 10.41 6.62
3 ITROMIDI24698 37 F 90.53 25.51 98.30 4.70 4.13 1.58 1.50 2.85
4 ITROMIDI24232 31 F 67.82 40.16 57.68 8.68 12.30 12.64 13.99 5.14
5 ITROMIDI28626 16 M 74.98 69.50 129.00 26.8 30.20 4.12 6.29 17.02
6 ITROMIDI1558 28 M 97.07 98.69 98.00 1.02 1.20 0.49 0.60 4.37
7 ITROMIDI5272 27 F 95.50 85.40 72.57 88.4 100.00 22.84 15.65 21.51
Panel A: Tests leading to kiwifruit LTP suspected reactivity are reported.
APC: Allergome Personal Code used in the InterAll e-record.
u Double Blind Placebo Controlled Food Challenge; GI: gastro-intestinal tract symptoms including vomiting and abdominal pain; OAS: oral allergy syndrome; URT:
Urticaria.
*Results of skin testing performed with green kiwifruit are expressed as mm
2.
**ISAC and CAP IgE results are expressed as kU/l.
Panel B: In vivo and in vitro results of kiwifruit LTP testing are reported.
APC: Allergome Personal Code used in the InterAll e-record.
*Results of skin testing are expressed in mm
2.
**ISAC and CAP IgE results are expressed as kU/l. A streptavidin-CAP has been used for kiwifruit LTP IgE detection.
uu In-house Pru p 3 preparation used throughout the study was immobilized on ISAC Exp96.
doi:10.1371/journal.pone.0027856.t001
Table 2. Skin test and IgE data on 44 peach allergic subjects.
Skin Test* ISAC Exp96 IgE6
nPru p 3 nAct c 10 nAct d 10 nPru p 3 nAct c 10 nAct d 10
Tested 44 44 44 44 44 44
Positive 44 32 32 44 29 27
% 100 72.7 72.7 100 65.9 61.4
Median 48.83 18.00 15.00 4.68 0.42 0.48
Min 1.40 6.20 2.60 0.10 0.10 0.10
Max 195.00 148.65 159.00 55.60 37.12 34.57
*Skin test reactivity is reported as wheal area (mm
2).
u ISAC Exp IgE values are reported as kU/l.
doi:10.1371/journal.pone.0027856.t002
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KF species.
nAct c 10 and nAct d 10 purification
The recovery of the pure protein was about 0.4 mg per gram of
green and gold KF seeds. The pulp was not used for LTP
preparation. Protein concentration was estimated on the basis of
the molar extinction coefficient at 280 nm (3480 M
21 cm
21).
Purity of the protein preparations was checked by SDS-PAGE,
RP- HPLC and N-terminal amino acid sequencing.
Full primary structure elucidation of nAct d 10
The direct sequencing of the N-terminal region of native nAct d
10 produced 17 identifiable amino acid residues, AVSCGQVD-
TALTPCLTY (Figure 1). A small fraction of the molecules
contained the amino acid threonine (T) rather than alanine (A) as
first residue. The N-terminal sequence of nAct c 10, comprising 17
amino acid residues, was identical to that of nAct d 10
(AVSCGQVDTALTPCLTY), and no heterogeneity at the first
positionwasobserved.Thecompleteaminoacid sequenceofnActd
10 was elucidated by automated sequencing of peptides resulting
from the enzymatic digestion of denatured and S-pyridilethylated
protein. Most of the primary structure was obtained by aligning the
amino acid sequence of peptides from trypsin and Asp-N digestions,
whereas the regions corresponding to the residues 18–35 and 36–42
were obtained by sequencing peptides from chymotrypsin digestion.
Figure 1 shows only thepeptides necessaryto elucidatethecomplete
amino acid sequence. nAct d 10 comprises 92 amino acids
producing a molecular mass of 9,458 Da for the most abundant
isoform, having alanine at the N-terminus. The 100% sequence
identity in the N-terminal region, together with the observation that
nAct d 10 and nAct c 10 have the same chromatographic behavior
and very similar molecular masses as estimated by mass
spectrometry analyses (see below), suggested a very high structural
similarity between the two proteins. Therefore, only the full nAct d
10 primary structure was elucidated. The full amino acid sequence
of the nAct d 10 isoforms having alanine or threonine as N-terminal
residue, and the partial N-terminal sequence of nAct c 10, have
been registered in the UniProt Knowledgebase with the accession
numbers P85205, P85206, and P85204, respectively. Act c 10 and
Act d 10 are allergen names approved by the WHO-IUIS Allergen
Nomenclature Subcommittee (www.allergen.org), and encoded
5735 and 5737, respectively, in the Allergome database (www.
allergome.org).
Estimation of the molecular mass by mass spectrometry
The analyses by MALDI-TOF mass spectrometry of purified
nAct d 10 provided two values, 9.464 (620) and 9.484 (620) kDa,
in good agreement with the mass values deduced from the amino
acid sequence of the two isoforms having alanine (9.458 kDa) or
treonine (9.488 kDa) as N-terminal residues, respectively. A
molecular mass of 9.460 (620) kDa was obtained for Act c 10
by mass spectrometry.
Evaluation of the resistance to proteolysis
The analysis by SDS-PAGE and RP-HPLC of the LTP samples
subjected to digestion in SGF showed that nAct c 10 and nAct d
10, similarly to nPru p 3, are resistant to gastric digestion.
Moreover, in line with the results reported by Cavatorta et al. [22],
nPru p 3 was partially digested by trypsin, whereas nAct d 10 and
nAct c 10 appeared to be resistant to the same digestion (data not
shown).
Sequence identity and alignments among LTPs under
study
Homology search in Uniprot protein database carried out using
the BLAST algorithm (www.expasy.org) showed the sequence
identity between Act d 10 and other already known allergenic
LTPs to be not very high, ranging between 55% with Ara h 9
(isoform Ara h 9.0201) and 35% with Par j 2. Identities among the
full length amino acid sequence of the six allergenic LTPs under
study (Act d 10, Ara h 9, Art v 3, Cor a 8, Mor n 3 and Pru p 3) are
comprised in the 42–70% range (Figure 2, panel A). The sequence
identity values between Act d 10 and other allergenic LTPs, such
as Api g 2 (celery stalk), Cit s 3 (orange), Fra a 3 (strawberry), Lac s
1 (lettuce), Len c 3 (lentil), Lyc e 3 (tomato), Mal d 3 (apple), Ory s
14 (rice), Pla or 3 (plane tree pollen), Pru du 3 (almond), Pyr c 3
(pear), Sin a 3 (mustard), Tri a 14 (wheat), Vit v 1 (grape), Zea m
14 (maize), are comprised in the narrow range of 40–55% (data
not shown). The alignment of the amino acid sequences of the
LTPs analyzed in the present study (Figure 2, panel B) underlines
that the best conserved region is a stretch of 10 contiguous residues
(positions 45–54, Act d 10 numbering, Figure 2, panel B). Twenty-
Figure 3. Comparative skin testing and IgE detection using nAct c 10, nAct d 10, and nPru p 3 in 44 peach clinically allergic subjects
tested positive for nPru p 3 on ISAC 103. Panels A to I report correlation and concordance results for each paired allergen preparation and test
as in the graphs. The Spearman r correlation coefficient and the Fisher’s exact test have been used for statistical evaluations. Statistics are reported
below each graph. IgE results have been obtained using ISAC microarray Exp96 and reported as kU/l; skin test have been obtained by measuring
wheal areas and reported as mm
2
. For graphical visualization needs on log scales, zero values for the skin test have been set at 0.1 mm
2, and at
0.01 kU/l for ISAC values.
doi:10.1371/journal.pone.0027856.g003
Figure 4. IgE prevalence for nAct c 10, nAct d 10, rAra h 9, nArt
v 3, rCor a 8, nMor n 3, nPru p 3 on 431 sera. Prevalence has been
calculated on 431 patients having at least one positive IgE test for one
of the LTP under study. Asterisk marks LTPs tested on ISAC 103;
remaining have been tested on ISAC Exp96. Statistical comparative
evaluation has been performed using the x
2 test to evaluate the overall
differences among all seven values. Pair-wise comparison has been
performed using the Tukey post hoc test. ‘‘p’’ values, for paired letters
in italics on top of the two corresponding bars, were as follows: a:
p=0.00015; b, e, g, h, j, k, l, m:p ,0.0001; c: p=0.0076; d: p=0.00067; f:
p=0.0021; i: p=0.045.
doi:10.1371/journal.pone.0027856.g004
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27856Figure 5. Venn diagram representation of positive IgE results for selected LTPs. LTP specific IgE have been determined using ISAC Exp96,
excepting for nArt v 3 and rCor a 8where ISAC 103 has been used. Due to the highly similar behavior of the two kiwifruit LTPs, panel from B to E show
how the other four LTPs behave compared to nAct d 10 and nPru p 3. Absolute and relative IgE prevalence are given for each combination on graphs
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PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e27856four amino acids (26%) (yellow background) are conserved in all
the six aligned sequences, including the eight cysteine residues. Act
d 10 shares 18 additional residues with Pru p 3: two of them
(brown background) are present only in Act d 10 and Pru p 3,
whereas the remaining 16 shared residues (blue background) can
be found also in other aligned sequences but not all of them.
Twenty-one residues (23%) of Act d 10 are substituted in Pru p 3,
whereas they are conserved in at least one of the aligned sequences
(green background). A higher number of residues, namely 35
amino acids of Pru p 3 (38%), are substituted in Act d 10, but they
are conserved in at least 1 of the other sequences (red background).
Act d 10 and Pru p 3 do not share identical residues with any of
the other aligned sequences in 27 and 14 sequence positions,
respectively (white background).
as follows: Panel A: nAct c 10, nAct d 10, and nPru p 3; Panel B: nAct d 10, nPru p 3, rAra h 9; Panel C: nAct d 10, nPru p 3, nArt v 3; Panel D: nAct d 10,
nPru p 3, rCor a 8; Panel E: nAct d 10, nPru p 3, nMor n 3.
doi:10.1371/journal.pone.0027856.g005
Figure 6. Unsupervised two-way hierarchical clustering analysis of 431 subjects tested for IgE on the seven LTPs. Logarithmic IgE
value distribution has been used to generate the heat map. Subjects had at least one IgE-positive result to one LTP under study. LTP are reported on
the y-axis, subjects on the x-axis with their respective relative distribution scales. Black to dark red scale corresponds to IgE values from negativet o
strongly positive. Color key legend gives an approx idea of visualized IgE values.
doi:10.1371/journal.pone.0027856.g006
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sensitized to kiwifruit LTPs
Table 1 reports selected patients’ diagnostic profiles. All patients
reported a reliable clinical history of reactions when eating KF.
The IgE screening performed using the ISAC test revealed none of
the subjects to be sensitized by other KF allergens, namely nAct d
2, nAct d 5, nAct d 6, nAct d 7, nAct d 11, but one recorded
positive to Act d 1, whereas all were recorded IgE positive to nPru
p 3, the homologous peach LTP (Table 1, panel A). Patients were
then tested with a commercial KF extract both by ST and CAP.
Results were sometime weak, doubtful or even negative (Table 1,
panel A). All patients underwent DBPCFC, all stopped because
subjective and objective allergic symptoms appeared as reported in
Table 1, panel A. Thus this selected group of KF allergic patients
underwent ST with the purified KF LTPs and IgE detection by
mean of the biotinylated KF LTP coupled with the streptavidin-
CAP. All ST and CAP testing were scored positive for the two KF
LTPs (Table 1, panel B), whereas they were negative in 10 allergic
subjects used as controls. The same patients were finally tested IgE
positive for the two KF LTP preparations, along with the in-house
nPru p 3 one, on the ISAC Exp96 (Table 1, panel B). The two
proteins where thus considered clinically relevant allergens, and
the ISAC Exp96 a suitable tool for further investigations.
To confirm the findings of the previous set of tests and to start a
comparative evaluation of LTPs from different sources, a
preliminary extended in vivo and in vitro testing has been performed
by ST and by detecting IgE on ISAC Exp96, using identical nAct
c 10, nAct d 10, and nPru p 3 preparations in the two tests. Forty
four patients complaining about symptoms on eating peach,
enrolled on the basis of a positive DBPCFC or a reliable history of
recent anaphylaxis and tested positive for nPru p 3 on the routine
ISAC 103, were evaluated. Table 2 reports data obtained by ST
and IgE detection in this selected cohort of patients. All 44 subjects
had a positive ST to nPru p 3 (median wheal area 48.83 mm
2,
range 1.4–195) confirming the positive IgE result on ISAC 103
used for selection, and replicated on ISAC Exp96 (median
4.68 kU/l, range 0.1–55.6), without statistically significant differ-
ences when compared to ISAC 103 results. A slightly not
statistically significant different skin reactivity was recorded when
considering nAct c 10 (median wheal area 18.0 mm
2, range 6.2–
148.6) and nAct d 10 (median wheal area 15.0 mm
2, range 2.6–
159) (Table 2). To set the relationship between ST and IgE
detection, nPru p 3 results obtained in the two tests were
compared; no correlation was found between ST areas and IgE
values (Figure 3, panel A). When the ST was performed using the
two KF LTPs 31 subjects reacted to both allergen preparations,
whereas positive ST was recorded to one and not to the other in
one subject each (Figure 3, panel B). Similarly, IgE results detected
for the two molecules were compared without significant
differences (Figure 3, panel C). Differing from nPru p 3 ST versus
IgE data analysis, a non-overlapping reactivity, anyhow not
statistically different, has been found when considering nAct c 10
and nAct d 10 ST versus IgE positive subjects, but the correlation
between the ST induced wheal areas and the IgE values was
statistically significant, though the Spearman r value was just 0.54
and 0.56 for the two LTPs, respectively (Figure 3, panel D, E).
Finally, no statistically significant correlations were found when
ST and IgE results were compared between nAct c 10 and nAct d
10 versus nPru p 3 (Figure 3, panel F, G, H, I).
Overall the findings reported above preliminary marked
immunological differences between the LTPs from peach and
KFs, thus suggesting that the shared LTP reactivity recorded in
the first set of patients and leading to the identification of KF LTPs
could not be extended to all nPru p 3 positive subjects.
Defining the magnitude of kiwifruit LTP reactivity by
comparative skin testing and IgE detection toward other
LTPs
As from the previous section findings, showing heterogeneity
between LTPs from two allergenic sources in that small study
group, a larger study was set using the routine testing approach by
the ISAC microarray, in order to define any possible subsets
related to different LTP IgE recognition. A comparative
evaluation of seven LTPs was undertaken using the ISAC 103
and ISAC Exp96 microarrays in parallel.
Unless the original two population were defined on the basis of
being nPru p 3 IgE positive or negative as tested on ISAC 103,
additional nPru p 3 positive subjects were found in the control
population using the ISAC Exp96 microarray bearing a different
nPru p 3 preparation, thus raising the number of nPru p 3 positive
subjects from 259 to 296. The same control population revealed a
number of subjects being nPru p 3 IgE negative but positive to at
least one of the other LTPs, increasing the overall number of
subjects being positive to at least one of the LTPs from 296 to 431.
nAct c 10, nAct d 10, rAra h 9, nArt v 3, rCor a 8, and nMor n 3
were positive when nPru p 3 was negative in 48, 41, 17, 56, 43,
and 17 cases, respectively. The number of subjects positive to one
LTP as listed above and negative to all others was relatively low,
being 5, 0, 9, 25, 10, 9, 17. These prevalence were statistically
different only when considering nArt v 3 values versus KF LTPs,
peanut and mulberry ones. Absence of nAct d 10 exclusively IgE
positive subjects statistically differed to all the remaining LTPs
rather than nAct c 10 (data not shown). Raw prevalence are
reported in Figure 4, calculated on the subset of 431 patients tested
positive to at least one of the seven LTPs. An overall significant
p,0.0001 of the x
2 test has been obtained taking together the
seven prevalence, whereas not all prevalence were statistically
different when compared each other. For instance, nPru p 3 was
anyway the most prevalent sensitization with no difference only
when compared to nMor n 3. IgE sensitization to nAct c 10 and
nAct d 10 had statistically significant higher prevalence than the
mugwort and the hazelnut LTPs, but less prevalent than nMor n 3
Figure 7. IgE values box-plot representation considering
median values and 5–95 percentile distributions. IgE value
distribution is plotted for positive values. Kruskal-Wallis One-Way
ANOVA by Ranks test gave a statistically significant p value (,0.0001).
The pair-wise comparison with a Mann-Whitney test with Bonferroni
correction applied to LTP IgE results gave p values, considering paired
letters in italics on top of the two corresponding bars, as follows,: a:
p=0.00218; b, d, h:p ,0.0001; c: p=0.00014; e: p=0.00093; f:
p=0.00079; g: p=0.03402.
doi:10.1371/journal.pone.0027856.g007
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less prevalent IgE reactivity have been recorded for the mugwort
and the hazelnut LTPs being statistically different from all other
LTPs. Detailed statistics are reported in Figure 4.
To visualize exclusive sensitization to one LTP compared to
others, a series of Venn diagrams showing all possible logical
relations between our finite collections of IgE values obtained by
the two microarray testing, have been generated and reported in
Figure 5. The first Venn diagram as reported in Figure 5, panel A,
shows almost overlapping results between the two KF LTPs, and
non-overlapping results considering nAct c 10 and nAct d 10
opposed to nPru p 3. Due to the highly similar behavior of the two
KF LTPs, the following Figure 5 panels show how each of the
other four LTPs under study behaves compared to nAct d 10 and
nPru p 3. Venn diagrams change depending on individual LTP
features, further showing heterogeneity of the members of this
group of molecules. An index of the different reciprocal behavior
of the LTPs is the changing number of isolated positivity to the
three LTPs used in each graph depending on the third LTP used.
A cluster analysis performed using all subjects having IgE
positive results to at least one of the seven LTPs generated the heat
map shown in Figure 6. The overall picture shows the clustering
heterogeneity of both allergens and patients. LTP IgE recognition
by the sensitized subjects is well depicted for allergens by the
presence of the first two clusters segregating nArt v 3 and rCor a 8
reactivity apart from the other LTPs. A second dichotomy is
observed, separating the two KF LTPs from the remaining, also
representing, as expected, the two molecules to be the closest ones.
The remaining three LTPs form an additional cluster further
divided in two. Subject clustering is dispersed in a great number of
clusters, much reflecting the individual heterogeneity of LTP IgE
recognition.
Beside the evaluation of positive/negative results reported
above and clearly showing non-overlapping behavior among
LTPs, we sought to verify whether detected IgE value distributions
were different comparing the seven LTPs under study. A Kurskal-
Wallis test gave statistically significant results (p,0.0001), and,
when comparing the paired groups using the Mann-Whitney test
several statistically different findings were recorded at different p
values (Figure 7). Differing from prevalence results reported in
Figure 4, nAct c 10 and nAct d 10 showed the lowest median
values, having those within the 5–95 percentiles distributed in a
quite narrow range (Figure 7). Both their distributions did not
differ significantly from rAra h 9, nArt v 3, and rCor a 8 values,
whereas statistically significant differences were obtained when
comparison was carried out toward nMor n 3 and nPru p 3 IgE
value distributions. rAra h 9 and nArt v 3 behaved almost the
same differing only from nPru p 3. Overall evaluating the
distributions of IgE values further described the behavioral
heterogeneity within LTPs as allergens.
All the 1,003 paired results were then plotted considering
paired allergens as reported in Figure 8, panels A-I; Figure 9,
panels J-R; Figure 10, panels S-V. All comparisons were highly
statistically significant (p,0.0001). As reference, both for
statistical findings and graphical representations, the nAct c 10
versus nAct d 10 correlation was taken, having the highest
Spearman r (0.94) and x
2 (851.6) values (Figure 8, panel A).
Twenty-nine discrepant results out of 258 positive ones (11.2%)
for the two KF LTPs were recorded, being the lowest value
among the others. Discrepant results are clearly shown along the
X and Y axis and reported in the table underneath each graph.
Taking advantage of the availability of two different nPru p 3
preparations on the two microarrays in use, we plotted and
evaluated their IgE results, giving the Spearman r=0.84 and a
x
2=608 values as shown in Figure 8, panel B. Unless the statistics
were very good, a higher number of discrepant results (n=90;
27.9%) were recorded compared to the above reported results
obtained with two KF LTPs. A very good correlation was
recorded again just when comparing nMor n 3 and nPru p 3
(r=0.91 and a x
2=761.8) (Figure 10, panel V), showing also the
highest number of concordant positive results (n=260), whereas
all other correlations showed a quite broad range of values, being
the lowest r (0.35) and x
2 (107.2) when comparing nAct c 10 and
nArt v 3 (Figure 8, panel E), and the highest (0.88; 699.5) when
rAra h 9 and nMor n 3 IgE results were matched (Figure 9, panel
O). In many cases IgE plotted points showed no linearity at all,
being scattered in a broad area (Figure 8, panels E, F, G, H;
Figure 9, panels M, R; Figure 10, panel S). In other cases a
certain linearity was still present for part of the subjects, but part
of the values were anyhow plotted above or below the theoretical
central line (Figure 8, panels C, D, I; Figure 9, panels J, K, L, N,
O, P, Q; Figure 10, panels T, U). The highest number of
discrepant IgE results were recorded for the paired nArt v 3/nPru
p 3 results (n=226; 64.2%) (Figure 10, panel S), whereas those
recorded for rAra h 9/nMor n 3 (n=65; 21.8%) were very close
to the best ones reported above (Figure 9, panel O). Overall
evaluating IgE correlations among allergens under study shed
further light on LTP immunological heterogeneity.
IgE inhibition experiments
To define immunological relationships in terms of IgE binding
among LTPs, the SPHIAa assay was run using nAct c 10, nAct d
10, and nPru p 3 as inhibitor on the seven LTPs. The assay was
performed using ten individual sera selected for being IgE
positive to the three inhibitors as shown in Figure 11, where IgE
values for any given inhibited LTP are given for each of the ten
sera. All the positive allergens other than LTPs used for control
purposes for each of the samples gave no inhibition values (data
not shown). Full autologous IgE inhibitions on the two KF LTPs
were achieved, as well as with the homologous nPru p 3
preparation (Figure 11, panel A and B). As shown in Figure 11,
panel C to F, nPru p 3 fully inhibited all the other LTPs. The two
KF LTPs showed a serum/allergen dependent behavior, having
IgE inhibition values as follows: greater than 50% for all samples
(rAra h 9, Figure 11, panel C); spread between 0 and 100% (nArt
v 3, Figure 11, panel D); separated in two subgroups, one
achieving 100% the other staying below 70% (rCor a 8, Figure 11,
Panel E); hardly reaching 100%, and spread in a wide range, with
the lowest value at 29% (nMor n 3, Figure 11, panel F); not
reaching 100%, spread in a wider range, with the lowest value at
Figure 8. IgE value correlations for paired LTPs. All 1,003 subjects have been plotted in each graph. Flags A, B, C, D, E, F, G, H, I in figure 8
indicate them as parts of the results shown also in figures 9, and 10. Consecutive letters have been used on purpose through the three figures. The
* marks IgE detection performed on ISAC 103, remaining IgE determinations have been obtained by ISAC Exp96. For graphical visualization needs on
log scales, zero values for ISAC testing have been set to 0.01 kU/l. The Spearman r correlation coefficient has been calculated and the x
2 test has been
used for statistical purposes. Statistics are reported below each graph.
doi:10.1371/journal.pone.0027856.g008
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Figure 11 legend. As for some of the other experiments reported
above, minor differences between the two KF LTPs were
recorded also in the inhibition test. Overall, also IgE inhibition
experiments confirmed the immunochemical differences between
the two new KF LTPs and the peach one and the different
behavior in terms of epitope distribution, recognition and
inhibition by the three inhibitors.
Figure 9. IgE value correlations for paired LTPs. All 1,003 subjects have been plotted in each graph. Flags J, K, L, M, N, O, P, Q, R in
figure 9 indicate them as parts of the results shown also in figures 8, and 10. Consecutive letters have been used on purpose through the three
figures. The * marks IgE detection performed on ISAC 103, remaining IgE determinations have been obtained by ISAC Exp96. For graphical
visualization needs on log scales, zero values for ISAC testing have been set to 0.01 kU/l. The Spearman r correlation coefficient has been calculated
and the x
2 test has been used for statistical purposes. Statistics are reported below each graph.
doi:10.1371/journal.pone.0027856.g009
Figure 10. IgE value correlations for paired LTPs. All 1,003 subjects have been plotted in each graph. Flags S, T, U, V in figure 10 indicate
them as parts of the results shown also in figures 8, and 9. Consecutive letters have been used on purpose through the three figures. The * marks IgE
detection performed on ISAC 103, remaining IgE determinations have been obtained by ISAC Exp96. For graphical visualization needs on log scales,
zero values for ISAC testing have been set to 0.01 kU/l. The Spearman r correlation coefficient has been calculated and the x
2 test has been used for
statistical purposes. Statistics are reported below each graph.
doi:10.1371/journal.pone.0027856.g010
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PLoS ONE | www.plosone.org 14 November 2011 | Volume 6 | Issue 11 | e27856Figure 11. Single Point Highest Inhibition Achievable assay (SPHIAa) for LTP IgE inhibition. IgE values on graphs are reported as percent
inhibition. IgE values for each serum in each graph representation are given in brackets. The three inhibitors are indicated in the X axis, whereas on
top of each graph the LTP immobilized on the microarray whose IgE binding has been inhibited is reported. Statistical evaluations have been applied
to the three series using the Kruskal-Wallis One-Way ANOVA by Ranks , followed by the post hoc test of Nemenyi-Damico-Wolfe-Dunn comparing
paired series. Statistics are as follows: Panel A - nAct c 10: nAct c 10 Median=100%; Range 83.91–100%; nAct d 10 Median=100%; Range 97.92–
100%; nPru p 3 Median=100%; Range 78.03–100%; Kruskal-Wallis=n.s.s.; Panel B - nAct d 10: nAct c 10 Median=100%; Range 84.27–100%; nAct d
10 Median=100%; Range 98.67–100%; nPru p 3 Median=100%; Range 80.42–100%; Kruskal-Wallis=n.s.s.; Panel C - rAra h 9: nAct c 10
Median=79.62%; Range 50.18– 97.85%; nAct d 10 Median=85.39%; Range 51.00–100%; nPru p 3 Median=100%; Range 88.05–100%; Kruskal-Wallis
p=0.00061; nAct c 10 vs nAct d 10=n.n.s.; nAct c 10 vs nPru p 3 p=0.00019; nAct c 10 vs nPru p 3 p=0.0055; Panel D - nArt v 3: nAct c 10
Median=75.45%; Range 0–100%; nAct d 10 Median=79.04%; Range 0–100%; nPru p 3 Median=100%; Range 90.80–100%; Kruskal-Wallis p=0.0012;
nAct c 10 vs nAct d 10=n.n.s.; nAct c 10 vs nPru p 3 p=0.00078; nAct c 10 vs nPru p 3 p=0.0083; Panel E - rCor a 8: nAct c 10 Median=95.83%;
Range 32.44–100%; nAct d 10 Median=85.79%; Range 0–100%; nPru p 3 Median=100%; Range 80.01–100%; Kruskal-Wallis p=n.n.s.; Panel F -
nMor n 3: nAct c 10 Median=63.71%; Range 27.97–95.84%; nAct d 10 Median=67.06%; Range 43.65–97.31%; nPru p 3 Median=98.99%; Range
85.11–100%; Kruskal-Wallis p=0.00031; nAct c 10 vs nAct d 10=n.n.s.; nAct c 10 vs nPru p 3 p=0.00035; nAct c 10 vs nPru p 3 p=0.0011; Panel G -
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tissues by biochemical, immunological and clinical
methods
To verify whether the heterogeneous immunological behavior
between the two KF LTPs and the peach LTP could lead to define
a subset of patients who are also not clinically reactive to all LTPs,
we first performed a series of experiments to define the LTP
distribution within the KF tissues, namely the pulp and the seeds,
based on biochemical, immunochemical and clinical methods.
As reported in the first paragraph of the Result section, using
biochemical methods, seed and pulp extracts were fractionated by
RP-HPLC (Figure 12, panel A) and the separated protein
components were analyzed by N-terminal amino acid sequencing.
The analysis of a peak eluted at a retention time very similar to
that observed for nPru p 3 allowed the identification of nAct c 10
and nAct d 10 in the seed extracts from the gold (Figure 12 A, left)
and the green KFs (Figure 12 A, right), respectively (Figure 12,
panel A, upper parts), whereas that peak was lacking in the RP-
HPLC profiles obtained for the pulp extracts of the two KF species
(Figure 12, panel A, lower parts). Nevertheless, the fractions of
pulp extracts eluted at the retention time of nAct d 10 and nAct c
10 were collected and analyzed by N-terminal amino acid
sequencing. The results obtained confirmed the absence of
detectable amounts of nAct d 10 and nAct c 10 in the pulp
extracts. As the biochemical findings reported above seemed to be
quite conclusive, to increase the confidence with the negative data
we approached the issue of LTP distribution in KF tissues using
the SPHIAa as well. The inhibition was performed using the same
pulp and seed preparations from the green and gold KFs, along
with whole KF extracts. A pool of sera having IgE for both the two
KF LTPs was used as probe. As shown in Figure 12, panel B, full
or almost full IgE inhibition results were obtained with the whole
KF extracts and the seed ones, whereas the pulp gave either no
inhibition (green KF pulp on nAct c 10, Figure 12, panel B) or
inhibition values ranging between 18% and 28% (all other pulp/
allergen combinations in Figure 12, panel B). These slightly
positive results were replicated and could suggest the presence of
minimal amount of LTP in the KF pulp not detected by the
biochemical methods. The very low inhibition values were anyhow
not considered conclusive, and needing a third discriminating
proof. We thus performed in vivo skin testing with green KF seed
and pulp preparations in 21 selected subjects. As reported in
Figure 12, panel C, the comparative analysis showed statistically
significant different results between green KF seed and pulp
preparations, nevertheless some of the patients did react to the
pulp as better shown for individual patients in Table 3. As the key
values were those obtained on patients having severe clinical
reactions on KF ingestion, and high or very high ST and IgE
scores when tested with nAct c 10 and nAct d 10 (Table 3, lines
15–21), we concluded that tiny amount of LTP are present in the
KF pulp. We thus abandoned the idea of challenging KF clinically
allergic patients with the separated KF pulp.
Defining the tolerability of the green kiwifruit by nPru p 3
positive, nAct c 10/nAct d 10 negative subjects
Opposing to the study starting point, where patients used to
identify the new KF LTPs were isolated because of their combined
clinical and IgE reactivity to KF and peach, and coherently
following all the new findings reported above, showing heteroge-
neous behavior of single subjects toward one or the other LTP, we
sought to define the in vivo clinical reactivity to green KF in well
characterized peach allergic patients. We thus recruited patients
having different diagnostic profiles. All enrolled ones had to be
nPru p 3 positive with either a positive DBPCFC to peach or a
recent severe generalized reaction on peach ingestion. All
underwent the tests as reported in Table 3. Among the enrolled
ones we had 15 who passed the DBPCFC eating a full KF at the
end, and six who clearly showed symptoms after the challenge. As
shown in Table 3, the latter were all tested positive for almost all
preparations either by in vivo or in in vitro tests, whereas among the
KF tolerant in the majority of the cases the KFs LTP were tested
with negative results, but with exceptions, unless positive values
were in the lowest range for both ISAC and ST (Table 3). We thus
performed a statistical evaluation of test value distributions
between the tolerant and the non-tolerant subsets as reported in
Figure 13. Unless the number of enrolled subjects was not high, we
recorded statistically significant differences when nAct d 10 ISAC
IgE values and both KF LTPs ST values were compared, finally
showing the valuable diagnostic help of adding KF LTP to the
testing to identify patients having a inhomogeneous behavior
toward LTPs.
To note that the testing had a positive predictive value for those
whose KF avoidance remains mandatory. In addition to those
reported in Table 3, seven subjects, who were invited to
participate to the study, underwent tests foreseen in the first part,
where their diagnostic profile was recorded very similar to that
reported for patients 15–21 in Table 3 (data not shown). They
declined to undergo the DBPCFC. Six of 7 reported a generalized
reaction on KF ingestion sometime in the past, thus they found
our nAct c 10 and nAct d 10 positive tests ‘‘sufficient to prove their
clinically relevant allergy to KF’’.
In the attempt to explain why the nAct c 10 or nAct d 10
positive results were not accompanied by a clinical reactivity, we
simulated physiological digestion of the two KF LTPs as reported
above, and, using the SPHIAa, evaluated the retained capability to
induce IgE inhibition. nPru p 3 was comparatively evaluated, as it
is known to be resistant to digestion. The results showed that also
digestion resistant nAct c 10 and nAct d 10 are still active in the
IgE inhibition assay (data not shown).
Discussion
We herein report for the first time the identification of two new
LTPs from the gold and the green KFs and their characterization
as clinically relevant allergens. The primary structure of nAct d 10,
the one from green KF, has been fully elucidated, being the one of
nAct c 10 from gold KF very similar, mainly on the basis of the
almost overlapping findings described throughout the present
study. The identification process was straight forward as, using a
panel of other KF allergens we selected patients being IgE negative
for them and having just a positive IgE result for a potentially
homologous molecule, namely nPru p 3. This process is highly
suggested as leads to a secured evaluation of the newly identified
structure, without overlapping positivity as sometimes reported in
literature [23]. As the presence of still unknown KF allergens
cannot be excluded, patients from the present study should be re-
evaluated on the basis of a more comprehensive allergen panel.
Unless we started the identification using subjects having the
double clinical reactivity to peach and KF, the first evidence that
nPru p 3: nAct c 10 Median=50.21%; Range 18.25–95.94%; nAct d 10 Median=60.55%; Range 39.55–98.11%; nPru p 3 Median=100%; Range 97.44–
100%; Kruskal-Wallis p,0.0001; nAct c 10 vs nAct d 10=n.n.s.; nAct c 10 vs nPru p 3 p,0.0001; nAct c 10 vs nPru p 3 p=0.0003.
doi:10.1371/journal.pone.0027856.g011
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PLoS ONE | www.plosone.org 16 November 2011 | Volume 6 | Issue 11 | e27856Figure 12. Biochemical, immunochemical, and clinical evaluation of LTP distribution in kiwifruit tissues. Panel A, Left: RP-HPLC profiles
of the pulp (upper part) and seed (lower part) protein extracts of gold kiwifruit tissues. The amount of loaded proteins was 1 mg. The arrow indicates
the elution time of Act c 10. Panel A, Right: RP-HPLC profiles of the pulp (upper) and seed (lower) protein extracts of green kiwifruit tissues. The
amount of loaded proteins was 0.3 mg. The arrow indicates the elution time of Act d 10. Panel B: Single Point Highest Inhibition Achievable assay
(SPHIAa) using pulp and seed extract preparations from green and gold kiwifruits. Grey bars: total kiwifruit extracts; White bars: bars: kiwifruit pulp
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homogeneous group of molecules came by the comparative
evaluation of primary structures and the preliminary extended
parallel comparative testing with the peach LTP on the 44 peach
allergic subjects. The former is the biochemical evidence that Act
d 10 is not closely related to anyone of the already known
allergenic LTPs. In fact, the observed sequence identities are never
higher than 55% and generally fall in the narrow range of 40–
55%, whereas more closely related LTPs display higher values.
For instance, identities of 97, 91, 88, 87 and 79% are obtained
when Pru p 3 sequence is compared with Pru du 3, Pru ar 3, Pru d
3, Pru av 3, Mal d 3 ones, respectively [19]. The alignment of Act
d 10 sequence with the five LTPs included in this study (Ara h 9,
Art v 3, Cor a 8, Mor n 3, Pru p 3) and the additional fifteen
allergenic LTPs listed above shows that seven residues, G31, D45,
R46, L53, K54, A67, S83 (Act d 10 numbering) and the 8 cysteine
residues, playing a key role in the stabilization of the tertiary
structure of the LTP1 proteins, are conserved in all these
molecules (data not shown). The analysis of the alignment also
shows that, depending on the compared sequences pair, unique
combinations of conserved residues occurr. The absence of
sequence regions conserved in all the LTP1 suggests that the
existence of even one identical epitope, shared by all the allergenic
LTP1, is unlikely. It is coincevable that a complete or partial
epitope sharing can be found only when closely related LTPs are
compared. The observed sequence micro-heterogeneity, mainly
found in distantly related LTPs, could be thus the main cause of
inhomogeneous epitope patterns producing inhomogeneous LTP
IgE recognition as shown at least on the LTP1 included in the
present study.
About comparative testing, our data on a huge population
where just one LTP, nPru p 3, was tested did not arise such
suspicion [4]. Reports from literature leading to characterization
of new LTPs are much focusing the description of the new allergen
extracts; Black bars: kiwifruit seed extracts. Panel C: Skin test using nAct c 10, nAct d 10, and green kiwifruit seed and pulp preparations. Skin test
wheal areas have been recorded and expressed in mm
2. The Mann-Whitney test applied to paired test result distributions gave p values as follows:
Act c 10 vs Act d 10 p=n.n.s.; Act d 10 vs Seeds p=n.n.s.; Act d 10 vs Pulp p,0.004; Seeds vs Pulp p,0.017.
doi:10.1371/journal.pone.0027856.g012
Table 3. Diagnostic and clinical profiles of patients enrolled because of clinical allergy to peach and positive or negative kiwifruit
LTP test results.
InterAll APC Code Age Gender ISAC IgE6 Skin test* DBPCFC66
nAct c
10
nAct d
10 nPru p 3 nAct c 10 nAct d 10 Seed** Pulp** nPru p 3 Green Kiwi
1 ITROMIDI6320 37 M Neg Neg 9.92 Neg Neg 41.00 74.80 315.30 NR
2 ITROMIDI48581 16 F Neg Neg 4.09 Neg Neg Neg Neg 98.34 NR
3 ITROMIDI22317 38 F Neg Neg 30.54 Neg Neg Neg Neg 7.40 NR
4 ITLATAM10845 20 F Neg Neg 1.10 Neg Neg 24.00 Neg 125.00 NR
5 ITROMIDI46312 18 F Neg Neg 4.42 Neg Neg 9.20 6.60 24.50 NR
6 ITROMIDI46322 30 F Neg Neg 8.13 Neg Neg Neg Neg 142.00 NR
7 ITROMIDI3010 33 F Neg Neg 0.75 5.70 Neg 3.20 4.40 97.00 NR
8 ITROMIDI960 48 F Neg Neg 1.70 6.50 27.40 5.60 Neg 61.83 NR
9 ITROMIDI2444 45 F Neg Neg 4.91 11.50 10.00 ND ND 139.00 NR
10 ITROMIDI53147 35 F 1.01 0.11 1.50 Neg Neg 12.80 17.20 54.78 NR
11 ITROMIDI1899 38 M 0.16 0.53 0.22 Neg Neg 14.00 10.40 49.20 NR
12 ITROMIDI18019 39 F 1.94 1.27 8.91 Neg Neg 21.90 Neg 71.60 NR
13 ITROMIDI16304 20 F 5.4 7.16 29.08 Neg Neg Neg Neg 53.00 NR
14 ITROMIDI41039 20 F 6.07 5.80 3.38 166.40 75.50 26.00 19.00 134.30 NR
15 ITROMIDI53368 38 F 0.95 0.91 1.19 213.80 148.40 184.80 20.20 30.40 NR
16 ITROMIDI2126 25 F 0.14 0.10 4.67 Neg Neg 53.70 28.80 83.50 OAS
17 ITROMIDI10971 17 M 21.9 21.40 55.6 309.00 267.80 176.70 36.60 100.40 URT - ANG
18 ITLATAM7614 15 M 0.26 0.46 4.06 76.30 65.00 80.80 52.30 52.60 OAS - ANG
19 ITROMIDI2889 27 F 0.33 0.47 8.79 194.60 256.00 88.00 25.00 215.90 OAS - ANG
20 ITROMIDI1911 32 M 37.12 34.57 12.31 102.20 146.50 156.20 41.00 73.80 GI - URT
21 ITROMIDI1181 22 F 0.13 0.75 4.94 29.50 36.50 25.70 24.00 67.70 GI - URT
APC: Allergome Personal Code used in the InterAll e-record.
u ISAC IgE results are expressed as kU/l.
*Results of skin testing are expressed in mm
2.
**Seed and Pulp extracts were from green kiwifruit. Subjects 1, 4, 5, having positive ST to seed or pulp preparations were found positive to other kiwifruit LTP allergens,
Act d 11, profilins, and Act d 2, respectively.
uu ANG: Angioedema; GI: gastro-intestinal tract symptoms including vomiting and abdominal pain; NR: No reactions; OAS: oral allergy syndrome; URT: Urticaria.
doi:10.1371/journal.pone.0027856.t003
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LTP allergy. We could conclude the same if we stopped our
allergen characterization looking at few, highly affected patients as
many other reports do on allergens belonging to the same LTP
family [19,24–33]. Anyhow, during the time several Authors have
observed a certain inhomogeneous behavior of LTPs mainly using
IgE inhibition assays or parallel testing with LTPs [19,24,29,33–
39]. Cited studies, always performed on a limited number of
subjects, did not achieve the evidence, we are now reporting, of the
highly heterogeneous behavior of LTPs, leading in our opinion to
the need of a thorough testing of every single patient with the most
comprehensive panel of available LTPs. More emphasis on the
topic has been recently brought by Tordesillas et al. [39]. In their
study, carried out on a limited number of subjects as well, they
included LTPs biochemically-wise quite distant from each other in
term of sequences, testing Pru p 3, a very close one, Mal d 3, some
as distant as those used in our study (Art v 3, Sin a 3, Tri a 14) and
two very remote ones (Par j 1, Ole e 7). Authors finally raised the
doubt that the biochemical grouping of allergens can be
misleading in the allergy diagnosis. Although Par j 1 and Par j 2
[19] seem definitely placed outside the LTP IgE co-recognized
molecules, additional data are required before such conclusion can
be drawn at least for Ole e 7, Tri a 14, and Sin a 3.
Regarding molecule to molecule immunological relationships,
some studies reported on the need of studying conformational
epitopes shared or not by different LTPs [40–42]. Using the
peptide display library authors searched for identification of
peptides working as mimotopes of surface IgE binding regions,
giving evidence of the heterogeneity of the molecule surface in
LTPs. We tried to give a contribution to the molecule to molecule
relationship understanding by extensively studying IgE correla-
tions between paired molecules. IgE correlations have been
already reported in few studies in a limited number of subjects,
sometimes showing similar results with ours, sometime different
[28,32,38]. In our opinion this much depend on recruitment
selection criteria used to enroll patients in studies. Gadermaier
et al. [43] performed IgE correlation experiments on Api g 2, Art v
3, Pru p 3 on a quite large population reporting some findings
shown in the present manuscript in a more comprehensive way. In
the two studies the sampling bias has been avoided by enrolling
patient consecutively without preliminary selection criteria and in
a high number. This strategy seems to hold true also for
comparing quality of different preparations of the same allergen,
as in our case for nPru p 3 from two different providers.
Incidentally we have been able to compare them in this high
throughput study. Although the large majority of samples were
double positive for the two preparations immobilized on the two
microarrays, the discrepant results, mainly when high IgE levels
are recorded and replicated, require further investigation focusing
on both the spotting technology but mainly on the allergen
preparation quality.
In the need of profiling patients reporting KF allergy, we used in
collaboration with other research groups, Pru p 3 as representative
LTP also for KF LTP [44]. After the findings reported in our study
we presume that in that study there has been an overestimation of
the KF LTP involvement in the patient profiling. Such
substitutions should be discouraged as they can lead to over or
underestimation of the phenomenon as might be argued for other
studies [45]. Nevertheless, unless a high number of LTPs is now
available for testing, there are studies claiming the possibility of
performing diagnosis and epidemiology of LTP or other allergen
sensitizations by using just one representative molecule for each
group [46–50]. Evidence of a non-homogeneous behavior of
profilins as allergens has already been reported by Radauer et al.
[51]. Recently the heterogeneous behavior of patients toward Bet
v 1 homologous molecules when describing a new Bet v 1-like
molecule from green KF, Act d 11 [14], and within the established
hevein-like molecule group [52] have been reported. Both studies
suggest how the combination of a microarray testing system and
panel of molecules might be useful for describing single patient
profiles and the overall molecule group picture at the same time.
In a very recent paper from Gadermaier et al. [43] this new
approach is given for LTPs starting from Api g 2, the celery stalk
Figure 13. IgE and Skin test result evaluation comparing
patients being tolerant or not to green kiwifruit ingestion.
NT=Green kiwifruit Non-Tolerant; T=Green kiwifruit Tolerant. Panel A:
IgE values obtained testing serum samples for nAct c 10, nAct d 10, and
nPru p 3 on ISAC Exp96. The Mann-Whitney test applied to tolerant
versus non-tolerant patients for each test gave p values as follows: Act c
10-T vs Act c 10-NT p=n.n.s.; Act d 10-T vs Act d 10-NT p,0.05; Pru p 3-
T vs Pru p 3-NT p=n.n.s. Panel B: Skin test wheal area values obtained
for nAct c 10, nAct d 10, and nPru p 3. Skin test wheal areas have been
recorded and expressed in mm
2. The Mann-Whitney test applied to
tolerant versus non-tolerant patients for each test gave p values as
follows: Act c 10-T vs Act c 10-NT p,0.02; Act d 10-T vs Act d 10-NT
p,0.01; Pru p 3-T vs Pru p 3-NT p=n.n.s.
doi:10.1371/journal.pone.0027856.g013
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could drive to wrong conclusions, whereas exploring the behavior
in a larger cohort and combining other experimental approaches
as in the present study highlights the inhomogeneity of LTP as
allergens. Other collaborative studies have been recently accepted
for publication showing or reinforcing the demonstration of the
valuable use of the multiple homologous molecule approach for
Bet v 1-like, tropomyosins, profilins as pan-allergens [53,54].
Overall we can describe the clinical relevance of our findings as
follows: we found non-symptomatic subjects as in previous studies
[28,38,55], or different clinical pictures to the leading Pru p 3
sensitization as described so far [36,37]. As shown in several
experiments reported in the present study, each LTP shows a
different recognition pattern and we could not come to our
conclusions without considering such heterogeneity. Thus, level of
Pru p 3 IgE cannot account of sensitization toward other LTPs, as
recently proposed by Asero et al. [49], whereas the finding of
several subjects having isolated IgE positivity to single LTP should
be further explored with a broader allergen panel in order to
identify whether sources other than peach can account of an IgE
sensitization leading to a different LTP subset. At this regard,
previously reported data on Art v 3, the mugwort pollen LTP,
seem to support this idea [33,43]. As levels of IgE in case of
isolated positivity were never high, we can speculate about single
epitope IgE recognition creating the condition for a positive in
vitro test but no clinical reactions. Although requiring further
studies on a higher number of subjects, our approach leads to
allergy test driven decision on what to exclude but, most
importantly, on what to leave in patient’s diet, we do consider
this approach of great clinical relevance as it has never been
proposed before. Having robust data coming from a broad positive
and negative IgE testing will help the clinical allergist in her/his
therapeutic decisions, and hopefully reduce the fear of eating any
plant-derived food, typical behavior of LTP allergic patients. The
re-introduction of KF under supervision in a clinical setting ready
for emergencies is the suggested strategy, mostly in those patients
showing discordant in vivo/in vitro results as herein reported.
After all, it remains that LTP represent a cross-sectional group
of allergens having a patient’s related IgE co-recognition. What
should be avoided is the interpretation of LTP as part of a given
allergenic source in the so called component-resolved diagnosis
[26,29,44,45,56–59]. This concept leads back to the allergenic
extract-based diagnosis, whereas the allergist needs to be informed
on the extension of the IgE recognized homologous molecules and
translate that for the patients.
Last important finding of our study is the original distribution of
LTP within the KF tissues. LTP is generally reported to be found
on the surface of fruits, as in the case of peach [60]. We found a
great gap in the presence of the molecule comparing the seeds and
the pulp, unless a tiny amount might be found in the latter that we
considered enough to exclude the use of KF pulp separated from
seed in KF allergic patients. Furthermore, this can justify why in a
recent study from us where green KF were evaluated at different
ripening stage we did not describe the LTP band [61]. Moreover,
the absence of good quantity of the LTP in the pulp raises doubts
about the usefulness of the prick-prick test technique as reported
negative in some subjects in the present study.
In conclusion, we suggest the use of the microarray testing
system bearing panels of homologous molecules as it adds much to
our comparative knowledge on biochemical, immunochemical
and clinical differences between closely related structures. Clinical
allergists might take advantage of missing IgE recognition of one
or the other LTP for keeping the specific food in patient’s diet,
avoiding useless exclusion, generally leading to deterioration of
patient’s quality of life.
Furthermore, we herein document the need of having the
microarray-based testing available for routine allergy diagnosis
workup, as it creates the conditions for generating a wealth of data
without selection biases and on cohorts otherwise not approach-
able, as we cannot exclude a different behavior of patients living in
different geographical areas. As preliminary depicted in a review
by us [3] and more recently discussed on defining the best
diagnostic approach to atopic dermatitis patients [62], the most
extended and comprehensive panel of molecules will lead us to
increase our knowledge on reciprocal IgE recognition of allergenic
molecule and of patient’s immune profiling, leading to a great
improvement of disease management.
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